Somatic deletion of the PFDN5 gene has been observed in canine mammary cancer, particularly in solid tumors, correlating with a high Ki-67 score (tumor proliferation marker) (Hennecke et al. 2015). This evidence concerns the gene PFDN5 and breast cancer.